GlassScriptPhysician profile
Haley Harkendorff
NPI 1447622592
$3,269.14
in general payments reported to CMS, 2019-2025
21 companies · $804 in 2025
The $804 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $17.94 · 2022: $521 · 2023: $1,073 · 2024: $853 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,630 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,629.98 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $794.52 | 2022-2025 | |
| Abbvie INC. | $738.23 | 2022-2025 | |
| Genzyme Corporation | $379.81 | 2022-2025 | |
| Janssen Biotech, INC. | $290.27 | 2022-2025 | Tremfya, Remicade, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $222.62 | 2022-2025 | Ilumya, Winlevi |
| Ucb, INC. | $139.43 | 2022-2025 | Bimzelx, Cimzia |
| Lilly USA, LLC | $137.96 | 2022-2025 | Olumiant, Taltz, Ebglyss |
| Regeneron Healthcare Solutions, INC. | $137.60 | 2023-2025 | Dupixent, Libtayo |
| Galderma Laboratories, L.P. | $105.24 | 2024 | |
| Leo Pharma INC. | $43.27 | 2022-2025 | Anzupgo |
| E.R. Squibb & Sons, L.L.C. | $42.88 | 2023 | Sotyktu |
| Incyte Corporation | $40.78 | 2022-2023 | Opzelura |
| Krystal Biotech INC | $29.88 | 2023 | Vyjuvek |
| Organon LLC | $27.74 | 2025 | Vtama |
| Almirall LLC | $26.29 | 2025 | Cordran |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $23.15 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $22.88 | 2024 | Cabtreo |
| Arcutis Biotherapeutics, INC. | $19.95 | 2024 | Zoryve |
| Dermira, INC. | $17.94 | 2021 | |
| Dermavant Sciences, INC. | $14.93 | 2023 | Vtama |
| Pfizer INC. | $13.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Harkendorff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.